Abvc biopharma reports second quarter 2022 financial and operational results

Fremont, ca, aug. 15, 2022 (globe newswire) -- via newmediawire – abvc biopharma, inc. (nasdaq: abvc), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, cns, and ophthalmology, today announced its financial and operating results for the second quarter of 2022.
ABVC Ratings Summary
ABVC Quant Ranking